Home › Geographic Atrophy › Illinois
Geographic Atrophy clinical trials in Illinois
9 studies for Geographic Atrophy are looking for participants at sites in Illinois.
Cities in Illinois
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
- University Retina, Lemont
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 23, 2026 · NCT06557460A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- University Retina - Lemont- Site Number : 8400005, Lemont
RecruitingPhase 1/2
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234A Study in Adults With Geographic Atrophy
- University Retina and Macula Associates, P.C., Lemont
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- University of Illinois at Chicago, Chicago
- Retinal Vitreal Consultants, Chicago
- The University of Chicago, Chicago
- and 3 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- University Retina, Lemont
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Northwestern Medical Group, Chicago
- The University of Chicago Medicine Duchossois Center for Advanced Medicine, Chicago
- Retina Associates, Ltd., Elmhurst
- and 1 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- University Retina and Macula Associates, Oak Forest
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
- University Retina and Macula Associates, Oak Forest
RecruitingObservational study
Ages 55 and older · All sexes · Updated Sep 3, 2026 · NCT07144137Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- University Retina & Macula Associates, Lemont
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT06662162From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.